Table 2.

Non-nucleoside A _2B AR agonists analysed in this work (see Additional file 1 for structural details)

cpd	A1ARK i, nM	A2AARK i, nM	A2BAR EC50, nM	A3ARK i, nM
7	2.4	28	19	171
8	2.6	28	12	538
9	7.0	214	9	24
10	4.4	21	10	104
11	2.0	105	34	74
12	> 10000	> 10000	3	> 10000

The activity data are taken from Baraldi and co-workers (Baraldi et al. 2009).